Reduced-dose onabotuLinumtoxinA for Urgency Incontinence Among Elder Females (RELIEF): A Randomized Controlled Comparative Effectiveness Trial With Embedded Qualitative and Costing Analyses
Latest Information Update: 09 Feb 2025
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder; Urinary incontinence
- Focus Therapeutic Use
- Acronyms RELIEF
- 11 May 2023 Status changed from not yet recruiting to recruiting.
- 31 Mar 2023 Planned number of patients changed from 350 to 376.
- 31 Mar 2023 Planned initiation date changed from 15 Jan 2023 to 15 Apr 2023.